Skip to content

Development and Validation of a Predictive Index for Glycemic Control by Trends in Environmental Factors and Body Composition in Patients with Type 2 Diabetes Mellitus

The Synergistic Biomarker 50kHz Reactance and Walkability Score as a Revolutionary Predictor of Behavioral Change and Glycemic Control in Primary Care Diabetes Management - A Retrospective Cohort Study - A Retrospective Cohort Study of Behavior Change Prediction and Glycemic Control in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058452
Enrollment
195
Registered
2025-07-14
Start date
2022-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

Standardized lifestyle intervention (dietary therapy + exercise therapy + education)

Sponsors

Gunma Paz University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Newly diagnosed type 2 diabetes (within 3 months of diagnosis) Age 20-80 Baseline HbA1c 6.5-9.9% (48-85 mmol/mol) Available to participate in lifestyle intervention

Exclusion criteria

Exclusion criteria: Type 1 diabetes or secondary diabetes Pregnant or lactating Serious liver disease (ALT >3 times upper limit of normal) Heart failure (NYHA Class III-IV) Dialysis or eGFR <30 mL/min/1.73m^2 Contraindication to bioelectrical impedance measurement Not obtain informed consent

Design outcomes

Primary

MeasureTime frame
Achieve good glycemic control (HbA1c <7.0%) after 4 months

Secondary

MeasureTime frame
HbA1c change Body composition change (50 kHz reactance, muscle mass, body fat percentage) Muscle strength index change Composite body composition index change Intervention adherence

Countries

Japan

Contacts

Public ContactAkira Kimura

Gunma Paz University Department of Rehabilitation Sciences

kimuaki@nifty.com027-365-3366

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026